🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

For those who missed out don’t fear, the link is here! drive.google.com/file/d/1q51HmB… Thank you @Ozgur Mete and Peter Sadow, MD, PhD for the presentation! Sounak Gupta TreMar Samson W. Fine, MD Shivani Kandukuri, MD (she/her) Jitin Makker -6dmicroverse Endocrine Pathology

Many pathologists focusing on histology may may struggle with updates regarding the 3rd Edition of Bethesda System for Reporting Thyroid Cytopathology. Do not despair! Zubair Baloch and C. Christofer Juhlin are here to guide you, and they promise to keep it short! link.springer.com/article/10.100…

Tall cell papillary thyroid carcinoma is important to recognize, as this subtype is coupled to worse prognosis. But how tall is tall? And how rigid are the current criteria? Thankfully, Esther Diana Rossi and Dr Pantanowitz are on the ball! link.springer.com/article/10.100…

May issue is online !! Please check out our website for full texts !!

Announcing a free International Society of Gynecologic Pathologists live virtual special webinar on 06/06 by Drs. Ganesan, Soslow & Hodgson. A panel discussion with the experts! Audience can submit questions in advance at [email protected]. Register now at isgyp.ca #gynpath #pathtwitter #pathology

Hot off the press! Dr Mete and co-workers have analyzed a large cohort of appendiceal NETs, and identify three (not two!) subtypes of clinical importance. Now in open access in #endopath! Link below! Endocrine Society Springer Pathology UK Endocrine Pathology Society link.springer.com/article/10.100…

The 2023 JIF for Endocrine Pathology is 11.3! ⭐️ We are now the 2nd highest ranked journal among pathology journals, and within the top ten lists among endocrinology&metabolism! Fast turn-around time, superb production and friendly editorial handling! Submit your article today!

Submit your research to Endocrine Pathology for more than just our impact factor. With an experienced, friendly editorial team, a broad readership, and a lightning-fast median handling time of just 3 days from submission to decision, you'll experience quality like never before!

Editor-in-Chief Dr Ozgur Mete and Springer Pathology are granting temporary free access to our special issues articles until 15th Oct to disseminate the knowledge! ENPA is a high-impact (IF 11.3) journal dedicated to endocrine pathology, endocrinology and endocrine oncology. 🔬🧬✨

Retroperitoneal tumor adjacent to the VCI in a 40 y/o male. Surgical excision is performed. Tumor is composed of nests and solid areas embedded in a highly vascular stroma, the cytoplasm is granular and partly vacuolated. Rather monotonous nuclei. Follow the thread for more!

Biomarkers for anaplastic thyroid cancer are urgently needed, as these tumors often lose thyroid lineage markers. One promising option? SATB2! Here's why it could make a difference. link.springer.com/article/10.100…

Our journal features two ground-breaking papers in which a molecular link between well-differentiated NETs and high-grade NECs is proposed, arguing that a subset of well-differentiated cases may be at risk of progression! link.springer.com/article/10.100… link.springer.com/article/10.100…

IS THIS A NICE FNA CASE OF THYROID FOLLICULAR NEOPLASM? No. Prostatic adenocarcinoma metastatis to supraclavicular lymph node! PSAP (+) #FNA #thyroid #Diff_Quik #cytopath #cytology #cytopathology Turkish Cytopathology

Dr. Mete: beware of using CD56, CD57, PGP 9.5, NSE for confirming neuroendocrine differentiation! Endocrine Pathology USCAP #USCAP2025

A study in Endocrine Pathology evaluates the use of pan-TRK immunohistochemistry (IHC) for detecting NTRK fusions in papillary thyroid carcinoma (PTC). The research highlights its correlation with histopathologic features and diagnostic utility. bit.ly/425ulT0 Endocrine Pathology

Busting the BRAF hype in papillary thyroid cancer! This study of 301 PTC patients found BRAF p.V600E is common - but not a crystal ball for recurrence. What did matter? Big nodal disease & being male. Nicole Cipriani link.springer.com/article/10.100…

Not all adrenal cancers are created equal! Oncocytic ACC may look intense under the microscope - but it plays nicer than conventional ACC. Smaller tumors, fewer recurrences, better survival. But beware: High Ki67 or advanced stage? Still trouble. link.springer.com/article/10.100…

Improving pre-operative binary grading: relevance of #p53 and #PR expression in grade 2 endometrioid #endometrialcarcinoma 🔬 bit.ly/3GdJk5T #IJGConline #Research #Prevention #Treatment #Diagnostic #GynCancer #GynOnc #WomenHealth #SoMe #SoMe4GynOnc Pedro T Ramirez

Big news! Endocrine Pathology now holds an Impact Factor of 14.7 - ranking us #2 out of 90 pathology journals. A huge thanks to our authors, reviewers, and readers. Submit your outstanding research and be part of the momentum!

A must-read in Endocrine Pathology: This review proposes a new classification system for neuroendocrine tumors of the prostate, addressing key gaps in diagnosis, terminology, and management. Stay informed! Link below: link.springer.com/article/10.100…